A 39-amino acid triple agonist peptide designed to target GIP, GLP-1, and glucagon receptors, extensively researched for its potential role in metabolic function and body composition studies. Premium-grade peptide intended for research applications only.
20 mg
A 39-amino acid triple agonist peptide designed to target GIP, GLP-1, and glucagon receptors, extensively researched for its potential role in metabolic function and body composition studies. Premium-grade peptide intended for research applications only.
20 mg
Inertia BioLabs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.